BioXcel Therapeutics Q1 EPS $(0.54) Beats $(0.59) Estimate, Sales $206.000K Miss $349.250K Estimate

Benzinga Newsdesk www.benzinga.com Neutral 45.6%

Neg 0% Neu 45.6% Pos 0%

Comments

No comments yet. Be the first!